Skip to main content
Clinical Trials/NCT03133780
NCT03133780
Completed
Phase 2

A Comparison of the Sedative Effect of Ketamine and Midazolam During Spinal Anaesthesia for Elective Unilateral Inguinal Hernia Repair: A Randomized Comparative Trial

Assiut University1 site in 1 country80 target enrollmentJuly 14, 2018

Overview

Phase
Phase 2
Intervention
Ketamine
Conditions
Sedation During Spinal Anesthesia
Sponsor
Assiut University
Enrollment
80
Locations
1
Primary Endpoint
Time for the onset of sedation in minutes assessed by modified observer's assessment of alertness/sedation score
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Patients during spinal anesthesia should be sedated.

Detailed Description

Spinal anesthesia offers a number of advantages to both the patient and the physician. However, patients are often reluctant to remain awake during a procedure. Sedation has been shown to increase patient satisfaction during regional anesthesia and may be considered as a means to increase the patient's acceptance.Therefore, provision of adequate sedation is important if the advantages of spinal anesthesia are to be fully appreciated.

Registry
clinicaltrials.gov
Start Date
July 14, 2018
End Date
March 7, 2020
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Seham Mohamed Moeen Ibrahim

Principal Investigator

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Male patients aged from 18 to 50 years old undergoing elective unilateral inguinal hernia repair with no neurological, cardiovascular and hepato-renal abnormalities.

Exclusion Criteria

  • Age: younger than 18 or older than
  • Psychatric or neurological disorders.
  • Cardiovascular disorders.
  • Coagulation disorders.
  • Contraindications to neuraxial block (allergy to L.A, peripheral neuropathy, prior spine surgery).

Arms & Interventions

Ketamine

Patients will receive IV ketamine 0.5 mg/kg diluted in normal saline to a volume of 50 ml over 10 min

Intervention: Ketamine

Midazolam

Patients will receive IV midazolam 0.03 mg/kg diluted in normal saline to a volume of 50 ml over 10 min

Intervention: Midazolam

Outcomes

Primary Outcomes

Time for the onset of sedation in minutes assessed by modified observer's assessment of alertness/sedation score

Time Frame: 90 minutes after spinal anesthesia

assessed by modified observer's assessment of alertness/sedation score

Study Sites (1)

Loading locations...

Similar Trials